Similar articles

• Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.

  Chung HT, Lee JS, Lok AS. Chung HT, et al. Hepatology. 1993 Nov;18(5):1045-9. Hepatology. 1993. PMID: 7693569
• The declining risk of post-transfusion hepatitis C virus infection.

  Donahue JG, Muñoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE. Donahue JG, et al. N Engl J Med. 1992 Aug 6;327(6):369-73. doi: 10.1056/NEJM199208063270601. N Engl J Med. 1992. PMID: 1320736
• [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].

  Sugg U. Sugg U. Beitr Infusionsther. 1988;21:177-81. Beitr Infusionsther. 1988. PMID: 2462972 German. No abstract available.
• Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.

  Kline WE. Kline WE. Beitr Infusionther Klin Ernahr. 1987;18:6-12. Beitr Infusionther Klin Ernahr. 1987. PMID: 3125834 Review. No abstract available.
• [Hepatitis C virus].

  Roggendorf M, Schlipköter U. Roggendorf M, et al. Beitr Infusionsther. 1991;28:13-21. Beitr Infusionsther. 1991. PMID: 1725610 Review. German.